Works matching IS 00192805 AND DT 2023 AND VI 169 AND IP 2
Results: 11
The origin of regulatory from the effector cells in LAG‐3‐marked Th1 immunity against severe influenza virus infection.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 167, doi. 10.1111/imm.13620
- By:
- Publication type:
- Article
Immunoglobulin γ marker genes as effect modifiers of Epstein–Barr virus‐multiple sclerosis association.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 242, doi. 10.1111/imm.13625
- By:
- Publication type:
- Article
Activation‐induced marker assays for identification of Trypanosoma cruzi‐specific CD4 or CD8 T cells in chronic Chagas disease patients.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 185, doi. 10.1111/imm.13622
- By:
- Publication type:
- Article
Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 204, doi. 10.1111/imm.13624
- By:
- Publication type:
- Article
The role of HMGB1 in COVID‐19‐induced cytokine storm and its potential therapeutic targets: A review.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 117, doi. 10.1111/imm.13623
- By:
- Publication type:
- Article
Systemic immune mediators reflect tumour‐infiltrating lymphocyte intensity and predict therapeutic response in triple‐negative breast cancer.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 229, doi. 10.1111/imm.13627
- By:
- Publication type:
- Article
New role of gramicidin A in RIG‐I‐like receptors‐mediated IFN signalling.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 219, doi. 10.1111/imm.13626
- By:
- Publication type:
- Article
An efficient combination immunotherapy for antitumor immunity without accelerating cardiac allograft rejection.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 157, doi. 10.1111/imm.13618
- By:
- Publication type:
- Article
Taurine promotes B‐cell activation by interaction with the V<sub>H</sub>/V<sub>L</sub> framework regions of B‐cell receptor.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 141, doi. 10.1111/imm.13617
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. i, doi. 10.1111/imm.13506
- Publication type:
- Article
Multiple breast cancer liver metastases response to macrophage‐delivered nanotherapy evaluated via a 3D continuum model.
- Published in:
- Immunology, 2023, v. 169, n. 2, p. 132, doi. 10.1111/imm.13615
- By:
- Publication type:
- Article